Assignee
HANML PHARM CO LTD
KR·0 granted patents·6 pending applications·0 citations·filing 2017–2020
Top patents by PatentIndex Score
6 records- 0150US2020230253A1Conjugate of iduronate-2-sulfataseHANML PHARM CO LTD·Filed 2018·Application pending·0 cites
- 0249US2022040262A1Therapeutic use of trigonal glucagon/glp-1/gip receptor agonist or conjugate thereof for liver diseaseHANML PHARM CO LTD·Filed 2020·Application pending·0 cites
- 0346US2022064248A1Pharmaceutical composition including insulin and glucagonHANML PHARM CO LTD·Filed 2019·Application pending·0 cites
- 0446US2020157172A1Novel therapeutic enzyme fusion protein and use thereofHANML PHARM CO LTD·Filed 2018·Application pending·0 cites
- 0543US2021046189A1Long-acting protein conjugates for brain targeting, a preparation method thereof, and a composition comprising the sameHANML PHARM CO LTD·Filed 2019·Application pending·0 cites
- 0639US2019167612A1Pharmaceutical formulation for oral administration with controlled dissolution rate comprising sustained-release pellets containing tamsulosin hydrochlorideHANML PHARM CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANML PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →